21:29:34 EDT Wed 15 May 2024
Enter Symbol
or Name
USA
CA



Reliq Health Technologies Inc
Symbol RHT
Shares Issued 203,133,929
Close 2023-08-17 C$ 0.47
Market Cap C$ 95,472,947
Recent Sedar Documents

Reliq rolls out postdischarge program, adds new clients

2023-08-17 09:40 ET - News Release

Dr. Lisa Crossley reports

RELIQ HEALTH TECHNOLOGIES, INC. LAUNCHES NEW POST-DISCHARGE PROGRAM AND SIGNS NEW HOSPITAL CLIENTS IN CA, FL AND PR

Reliq Health Technologies Inc. has launched a new postdischarge program for acute care hospitals and signed new hospital clients in California, Florida and Puerto Rico. The new contracts are expected to add 5,000 new patients to the platform every month by the end of 2024.

"We are very excited to announce our new postdischarge program aimed at acute care hospitals," said Dr. Lisa Crossley, chief executive officer at Reliq Health Technologies. "This new iUGO Care program supports patients who are being discharged from an acute care hospital to a wide range of care settings, from their own homes to inpatient rehabilitation, assisted living or skilled nursing facilities. Under the Centers for Medicare & Medicaid Services (CMS) hospital readmissions reduction program (HRRP), hospitals that fail to meet readmission targets can be assessed penalties equal to up to 3 per cent of their total Medicare reimbursement for the following year, translating to millions of dollars in lost revenue. In 2021, over 96 per cent of all Florida hospitals were assessed financial penalties due to readmission rates. According to Kaiser Health News, over 2,300 hospitals across the United States will pay a total of over $320-million in HRRP penalties in 2023 based on penalties assessed by CMS in 2022. Our clients' data shows that health care organizations using Reliq's iUGO Care platform have been able to drastically reduce their readmissions rates by over 90 per cent, avoiding financial penalties and improving patient health outcomes and quality of life. This program is a win-win for hospitals, clinicians, patients and their families."

"With iUGO Care's postdischarge program," continued Dr. Crossley, "patients receive targeted monitoring for the first 30 days after discharge to specifically prevent readmission to hospital and are then followed long term using the iUGO Care remote patient monitoring (RPM), transitional care management (TCM) and behavioural health integration (BHI) modules to improve long-term health outcomes and prevent complications that could lead to future hospitalizations. The company expects to add over 5,000 new patients per month to the platform by the end of 2024 through these new contracts, generating revenue of approximately $65 per patient per month at 75-per-cent gross margin."

About Reliq Health Technologies Inc.

Reliq Health Technologies is a rapidly growing global health care technology company that specializes in developing innovative virtual care solutions for the multibillion-dollar health care market. Reliq's powerful iUGO Care platform supports care co-ordination and community-based virtual health care. iUGO Care allows complex patients to receive high-quality care at home, improving health outcomes, enhancing quality of life for patients and families, and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER (emergency room) visits. Reliq Health Technologies trades on the TSX Venture Exchange under the symbol RHT, on the OTC (over-the-counter) market as RQHTF and on the Frankfurt Stock Exchange under the symbol A2AJTB.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.